Events

Our forthcoming conferences and webinars covering a range of Medicines Optimisation issues with SPS and other great speakers and presenters.
Search our library of past events for recordings, presentations, and interviews with speakers. All to inform your practice.

Recommended articles

Hormone Replacement Therapy availability varies currently. Check for available products and keep up-to-date. Supply content is maintained regularly by DHSC.
There is some evidence on the effect of bariatric surgery (gastric bypass) on specific medicines which may inform prescribing decisions for those patients.
Prescribing medicines by generic name is generally preferred but there are some circumstances when brand-name prescribing is warranted.
Factors to consider when deciding if the risk of shunt infections due to transient bacteraemia from invasive dental procedures warrants non-routine prophylaxis.
National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines
Pharmacy professionals can help ensure breastfeeding can continue whilst medicines are used. We guide on how to undertake this role.
Gabapentin or pregabalin can be taken while breastfeeding and with infant monitoring. Recommendations apply to full term and healthy infants only.
Approximate equivalent doses of oral benzodiazepines to diazepam. Doses are not exact because of differences between the medicines.
Guidance for pharmacy staff about what a person with sight loss might need from the pharmacy team to support them in using their medicines
Transcribing is accurately copying medication details. It requires assessment and mitigation against identified risks in different settings.
A knowledge of the different types of enteral feeding tube is important when recommending options for medicines administration
People often buy coenzyme Q10 supplements to help with statin-induced muscle symptoms. However, there is insufficient evidence to recommend its use.

COVID-19 Vaccines and Treatments

Resources covering pharmaceutical aspects of the vaccination programme specific to COVID-19 Vaccine Pfizer-BioNTech
Resources covering pharmaceutical aspects of the vaccination programme specific to COVID-19 Vaccine Moderna
Oral antivirals may reduce COVID-19 symptoms, progression, transmission, hospitalisation and mortality. We guide on successful deployment for Chief Pharmacists.
Resources covering pharmaceutical aspects of the vaccination programme common to all COVID-19 vaccines
Resources covering pharmaceutical aspects of the vaccination programme specific to COVID-19 Vaccine AstraZeneca
Pharmaceutical processes for Comirnaty (10 micrograms/dose) for Children 5 to 11 years, from initial ordering through to administration for PCNs and Trusts.
Characteristics of Pfizer's Comirnaty vaccines for adults/adolescents and children differ. Teams must understand the differences to ensure safety.
Summary information concerning COVID-19 vaccination in women of child-bearing age or who are pregnant

Recommended in PGDs

National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
A PGD template developed by SPS and supported by NASMeD and JRCALC for ambulance services commissioned by NHS England.
A PGD template developed by SPS and supported by NASMeD and JRCALC for ambulance services commissioned by NHS England.
A PGD template developed by SPS and supported by NASMeD and JRCALC for ambulance services commissioned by NHS England.
A PGD template developed by SPS and the Faculty of Sexual and Reproductive Health (FSRH).
A PGD template developed by SPS and the Faculty of Sexual and Reproductive Health (FSRH).
A PGD template developed by SPS and the Faculty of Sexual and Reproductive Health (FSRH).

Planning

Latest information on supply issues, actions to take, alternatives to use, and expected resolution dates. Content provided by DHSC and CMU.
Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.
Regularly updated new medicines material, in addition to our annual outputs
Regularly updated biosimilars material, in addition to our annual outputs
Regularly updated patent expiry material, in addition to our annual outputs

Recommended for primary care

Summarised recommendations and guidance for medicines requiring monitoring to save you time when you're making monitoring decisions with patients
All our advice on using medicines safely and effectively in patients with swallowing difficulties
All our training and guidance to help decision making about the use of medicines in breastfeeding
All our training and guidance to help decision making about the use of medicines in pregnancy